Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

Gene therapy represents a transformative approach in modern medicine, with the potential to address and cure a wide array of ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...